|Event Date/Time: Jan 21, 2010||End Date/Time: Jan 22, 2010|
â€œOverseeing risks & Optimizing drug safety in todayâ€™s pharma marketâ€
January 21st and 22nd 2010, Venue (TBC), Mumbai, India.
â€¢ Reviewing the best revenue generating models in suitable for current and future PV market.
â€¢ Grabbing the opportunity: learning about the challenges & complexities in the role
â€¢ Best practices, service offerings & deployment
â€¢ Global marketing strategies in order to engage with regulatory centres of excellence on pharmacovigilance and to understand their perspectives on best practice & future trends
â€¢ Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
â€¢ Exploiting the role of electronic data standards and controlled vocabularies in pharmacovigilance
â€¢ Positioning yourself in light of new market entries
â€¢ Analyzing the worldwide trends in PV & lessons for India.
â€¢ Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
â€¢ Updating yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practice in PV
â€¢ Dwell ahead of regulatory developments & improving your risk management strategies in a cost effective way
Pharmacovigilance is the science and actions unfolding to discovery, evaluation, understanding and prevention of adverse effects or any other likely medicine related problem. It aims to make use of medicines for the treatment or prevention of diseases. Though it is not intended to harm the patients during medicine use process, unfortunately some medicines often create slight or serious problems. Significant harm to even a few patients not only destroys the credibility of the medicine, the patients tend to loose trust on the the health system. A good Pharmacovigilance will identify the risks in the shortest possible time so that the harm can be avoided or minimized. The most frightening thought for any pharma company is the prospect of a drug withdrawal. As the costs associated with product withdrawals escalate the importance of pharmacovigilance increases.
Pharmacovigilance 2010 will discuss the on-going pressing concerns faced in drug safety, addressing the risks, timeline and budget constraint, whilst effectively tackling key challenges in overcoming trials agreement and site contract negotiation hurdles. This conference brings together top pharmaceutical, biotechnology and regulatory representatives in a forum that addresses the key issues of the industry. The in-depth program covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences. Understand and learn the latest insights, tools and knowledge to ensure that you and your firm to catch up with the current and future market. Analyze along with the market leaders on the latest developments in pharmacovigiance which would shape your organizationâ€™s wide risk management strategy.
It gives me immense pleasure in welcoming you to Virtue Insightâ€™s Pharmacovigilance 2010, and I wish you all the very best.
WHO SHOULD ATTEND:-
VPâ€™s, Directors, CROâ€™s, Heads and Managers of:
â€¢ Pharmacovigilance Strategy
â€¢ Drug Safety/Risk Management
â€¢ Information and Clinical Data Management
â€¢ Clinical Research
â€¢ Research & Development
â€¢ Product Safety/Assurance Assessment
â€¢ Patient Safety & Outcomes Research & Data Analysis
â€¢ Epidemiology project management
â€¢ Regulatory Affairs and Compliance
â€¢ Sales & Marketing
â€¢ Biotech manufacturers
WHY SHOULD YOU ATTEND?
Pharmacovigilance 2010 - â€œOverseeing risks & Optimizing drug safety in todayâ€™s pharma marketâ€
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
For more information on this conference and to book your seats â€“ Please visit - http://virtueinsight.com/site/Pharma_Details.aspx?SC_ID=3
Email your queries to firstname.lastname@example.org
Tel - 0091 44 64998743